Ambu has been awarded a contract with the US-based healthcare services provider Vizient, the Danish medtech company reports in a press release.
According to the firm, the deal will accelerate Ambu's fast-growing share of the single-use endoscope market. Vizient will aid this market expansion by offering its members Ambu's portfolio of products within bronchoscopy, urology, ENT and gastrointestinal endoscopy with pre-negotiated pricing and terms.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.